Tag: clinical trials

Documenting RBM Strategy for Health Authorities: What to Include and Why

Posted on By digi

Documenting RBM Strategy for Health Authorities: What to Include and Why In the context of clinical trials, especially those focused on ovarian cancer, ensuring compliance with regulatory requirements is a multifaceted process. Among the various strategies employed to enhance the efficiency of clinical trials, Risk-Based Monitoring (RBM) has emerged as a noteworthy approach. This step-by-step…

Read More “Documenting RBM Strategy for Health Authorities: What to Include and Why” »

Documentation for Regulators

Writing RBM Sections in Protocols, Clinical Study Reports and Briefing Packages

Posted on By digi

Writing RBM Sections in Protocols, Clinical Study Reports and Briefing Packages Understanding Risk-Based Monitoring (RBM) in Clinical Trials Risk-Based Monitoring (RBM) has become a fundamental component in the clinical trial landscape, particularly for eisf clinical trials. This methodology diverges from traditional monitoring approaches by emphasizing the identification and management of risks rather than merely on-site…

Read More “Writing RBM Sections in Protocols, Clinical Study Reports and Briefing Packages” »

Documentation for Regulators

Data Migration in Clinical Trials: Strategy, Validation and Risk Control

Posted on By digi

Data Migration in Clinical Trials: Strategy, Validation and Risk Control Introduction to Data Migration in Clinical Trials Data migration is a critical process within the landscape of clinical trials, specifically the eisf clinical trials framework. It involves transferring data from one clinical trial management system (CTMS) or database to another, which can occur during the…

Read More “Data Migration in Clinical Trials: Strategy, Validation and Risk Control” »

Data Migration & Integration

Planning Migrations Between EDC Systems, Phases or Vendors

Posted on By digi

Planning Migrations Between EDC Systems, Phases or Vendors Planning Migrations Between EDC Systems, Phases or Vendors In the complex landscape of clinical trials, particularly within the dynamic environment of clinical research, effective data management is a cornerstone of successful project execution. With the evolution of technologies and methodologies, many clinical operations and regulatory affairs professionals…

Read More “Planning Migrations Between EDC Systems, Phases or Vendors” »

Data Migration & Integration

Missing Data in Clinical Trials: Designing Strategies, Not Afterthoughts

Posted on By digi

Missing Data in Clinical Trials: Designing Strategies, Not Afterthoughts Missing Data in Clinical Trials: Designing Strategies, Not Afterthoughts Missing data is a pervasive issue in clinical trials that can significantly impact the integrity and validity of study results. With an increasing emphasis on high-quality and reliable data, it is essential for clinical operations, regulatory affairs,…

Read More “Missing Data in Clinical Trials: Designing Strategies, Not Afterthoughts” »

Missing Data Strategies & Sensitivity Analyses

Future Trends: AI, Machine Learning and Advanced Analytics in RBM

Posted on By digi

Future Trends: AI, Machine Learning and Advanced Analytics in RBM Future Trends: AI, Machine Learning and Advanced Analytics in Risk-Based Monitoring (RBM) Risk-Based Monitoring (RBM) in clinical trials is rapidly evolving, driven by the integration of advanced technologies such as artificial intelligence (AI) and machine learning (ML). This guide aims to provide clinical operations, regulatory…

Read More “Future Trends: AI, Machine Learning and Advanced Analytics in RBM” »

Technology Enablement for RBM

Working With Vendors to Co-Develop RBM Technology Roadmaps

Posted on By digi

Working With Vendors to Co-Develop RBM Technology Roadmaps Working With Vendors to Co-Develop RBM Technology Roadmaps Introduction to Risk-Based Monitoring in Clinical Trials The implementation of Risk-Based Monitoring (RBM) in clinical trials stipulates a systematic approach to overseeing trials with the aim of enhancing data integrity and participant safety while optimizing resources. This practice is…

Read More “Working With Vendors to Co-Develop RBM Technology Roadmaps” »

Technology Enablement for RBM

Integrating Reconciliation Outputs With Data Cleaning and Lock Readiness

Posted on By digi

Integrating Reconciliation Outputs With Data Cleaning and Lock Readiness Integrating Reconciliation Outputs With Data Cleaning and Lock Readiness In the landscape of clinical trials, the integration of data reconciliation outputs with comprehensive data cleaning processes is critical to achieving lock readiness. This ensures that datasets are not only complete and accurate but also compliant with…

Read More “Integrating Reconciliation Outputs With Data Cleaning and Lock Readiness” »

Data Reconciliation (SAE, PK/PD, IVRS)

Inspection Expectations for Evidence of Robust Reconciliation Processes

Posted on By digi

Inspection Expectations for Evidence of Robust Reconciliation Processes Inspection Expectations for Evidence of Robust Reconciliation Processes Clinical trials are integral to the advancement of medical knowledge and therapeutic practices, particularly in fields such as ovarian cancer clinical trials. As clinical operations, regulatory affairs, and medical affairs professionals engage in these processes, it is crucial to…

Read More “Inspection Expectations for Evidence of Robust Reconciliation Processes” »

Data Reconciliation (SAE, PK/PD, IVRS)

Common Mistakes in Estimand Definition and How to Avoid Them

Posted on By digi

Common Mistakes in Estimand Definition and How to Avoid Them Common Mistakes in Estimand Definition and How to Avoid Them The definition of an estimand is a critical element in the design and analysis of clinical trials. An estimand specifies what effect of a treatment is of interest and under what conditions it is estimated….

Read More “Common Mistakes in Estimand Definition and How to Avoid Them” »

Estimands & Handling Intercurrent Events